Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07827573 |
| Title | A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment (kalitERA) |
| Acronym | kalitERA |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hematology Oncology Salem | RECRUITING | Salem | Oregon | 97301 | United States | Details |
| Virginia Cancer Institute | RECRUITING | Richmond | Virginia | 23229 | United States | Details |
| Jewish General Hospital | RECRUITING | Montreal | Quebec | H3T 1E2 | Canada | Details |
| CHU de Québec - Hôpital du Saint-Sacrement | RECRUITING | Québec | Quebec | G1S 4L8 | Canada | Details |